Nektar Therapeutics (NKTR)

$ 0.67
   
  • Change Today:
    $-0.01
  • 52 Week High: $1.47
  • 52 Week Low: $0.49
  • Currency: US Dollars
  • Shares Issued: 180.09m
  • Volume: 2,047,821
  • Market Cap: $119.94m
  • RiskGrade: 333

Puretech Health confirms possible tie-up with Nektar Therapeutics

By Michele Maatouk

Date: Friday 07 Oct 2022

LONDON (ShareCast) - (Sharecast News) - PureTech Health said on Friday that it has exchanged indicative, non-binding proposals with US biopharmaceutical company Nektar Therapeutics regarding a possible combination.
Responding to press speculation a day earlier, PureTech said that it remains in discussions with Nektar about the proposal.

There can be no certainty that any firm offer will be made, nor as to the terms of any such offer, it said, adding that a further announcement will be made as and when appropriate.

Under UK takeover rules, Nektar has until 1700 BST on 3 November to either announce a firm intention to make an offer for the company or walk away.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

NKTR Market Data

Currency US Dollars
Share Price $ 0.67
Change Today $ -0.01
% Change -1.30 %
52 Week High $1.47
52 Week Low $0.49
Volume 2,047,821
Shares Issued 180.09m
Market Cap $119.94m
RiskGrade 333

What The Brokers Say

Strong Buy 3
Buy 3
Neutral 1
Sell 1
Strong Sell 0
Total 8
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 06-Jun-2025

Time Volume / Share Price
16:00 58,394 @ $0.67
15:59 300 @ $0.67
15:59 1,500 @ $0.67
15:59 4,000 @ $0.67
15:59 100 @ $0.67

Top of Page